BioAtla, Inc.
corporate_fare Company Profile
BioAtla, Inc. (OTC:BCAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for BCAB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- BioAtla to Reconvene Reverse Stock Split Vote; CEO Granted Super-Voting Share to Ensure Approval
- BioAtla Creates Super-Voting Share for CEO to Force Reverse Stock Split After Failed Shareholder Vote
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$59.61M
Diluted EPS
-$1.01
Op. Cash Flow
-$48.2M
Operating Income
-$59.3M
Cash & Equivalents
$7.12M
Debt / Equity
0.00×
Shares Outstanding
63.46M sh
Source: 10-K · filed 2026-03-31 · accession 0001193125-26-134499
show_chartPrice Chart
Loading chart...